{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["13"],"submitter":["Larranaga I"],"pubmed_abstract":["<h4>Introduction</h4>Patients with advanced chronic disease (ACD) experience transitions in their clinical stability, leading to increased healthcare resource use and costs. EU-funded ADLIFE digital intervention aimed to ensure their quality of life through individualised care plans, clinical decision-making support, and patient empowerment. This study assessed the impact and sustainability of ADLIFE.<h4>Materials and methods</h4>Target population included patients aged ≥55 years with heart failure (HF) and/or chronic obstructive pulmonary disease (COPD). First, a discrete event simulation (DES) model was developed using data from Osakidetza-Basque Health Service to represent the natural history of the disease. Second, ADLIFE intervention was implemented in four pilot sites: Spain, England"],"journal":["Frontiers in public health"],"pagination":["1682492"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12689975"],"repository":["biostudies-literature"],"pubmed_title":["Evaluation of the epidemiological and economic impact of the ADLIFE intervention on medium- to long-term in patients with advanced chronic disease."],"pmcid":["PMC12689975"],"pubmed_authors":["Maguire R","Mar J","McCann L","Miller M","Robbins T","Pournik O","Garton N","Fullaondo A","Arndt F","Gonzalez N","Gorostiza A","Zubeltzu B","Caballero J","Sarigul B","Juul NK","Tong C","Larranaga I","Laleci Erturkmen GB","Moro A","Grone O","Lopez B","Aguirre U","Vega R","Yilmaz G","Swoboda A","Lyngholm Christensen R","Yuksel M","ADLIFE Consortium","Ortega-Gil A","Blomeke-Cammin J","Kalra D","Morton A","Garcia-Lorenzo B","Arvanitis TN","Peake A","de la Torre J","Levy G","Aznar-Baranda JI","Vishnevetsky O","Verdoy D","Dichmann Sorknæs A","Panchal S","Alayo I","Lilja M","Koutsouradis K","Kaye R","de Manuel Keenoy E"],"additional_accession":[]},"is_claimable":false,"name":"Evaluation of the epidemiological and economic impact of the ADLIFE intervention on medium- to long-term in patients with advanced chronic disease.","description":"<h4>Introduction</h4>Patients with advanced chronic disease (ACD) experience transitions in their clinical stability, leading to increased healthcare resource use and costs. EU-funded ADLIFE digital intervention aimed to ensure their quality of life through individualised care plans, clinical decision-making support, and patient empowerment. This study assessed the impact and sustainability of ADLIFE.<h4>Materials and methods</h4>Target population included patients aged ≥55 years with heart failure (HF) and/or chronic obstructive pulmonary disease (COPD). First, a discrete event simulation (DES) model was developed using data from Osakidetza-Basque Health Service to represent the natural history of the disease. Second, ADLIFE intervention was implemented in four pilot sites: Spain, England","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025","modification":"2026-05-26T11:06:35.984Z","creation":"2026-05-24T03:11:18.294Z"},"accession":"S-EPMC12689975","cross_references":{"pubmed":["41383305"],"doi":["10.3389/fpubh.2025.1682492"]}}